Identification of risk factors associated with acute kidney injury in patients taking sodium‐glucose cotransporter‐2 inhibitors

Study Objective Studies have demonstrated sodium‐glucose cotransporter‐2 (SGLT2) inhibitors are kidney protective; however, their ability to cause hemodynamic changes may predispose patients to acute kidney injury (AKI). An FDA warning recommends evaluating for factors that predispose patients to AK...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmacotherapy 2024-03, Vol.44 (3), p.249-257
Hauptverfasser:	Schumacher, Christie, Chorpash, Amanda, Bolch, Charlotte, Eagan, Kellye, Nimer, Sara, Van Dril, Elizabeth
Format:	Artikel
Sprache:	eng
Schlagworte:	acute kidney injury adverse drug reactions Diabetes Diabetes mellitus (non-insulin dependent) Electronic health records Electronic medical records Epidermal growth factor receptors Glucose Kidneys Medical records Metabolism Risk factors Sodium-glucose cotransporter sodium‐glucose transporter 2 inhibitors Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!